Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes-Reference-Cited by-同舟云学术

Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes

Published:2020-08-12 Issue:3 Volume:31 Page:133-144
ISSN:0924-6479
Container-title:International Journal of Risk & Safety in Medicine
language:
Short-container-title:JRS

Author:

Isles Mike¹

Affiliation:

1. The European Alliance for Access to Safe Medicines, , , , UK

Publisher

IOS Press

Subject

Public Health, Environmental and Occupational Health,Health Policy,General Medicine

Reference34 articles.

1. Potential risks of pharmacy compounding;Gudeman;Drugs R D,2013

2. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe;Minghetti;Health Policy,2014

3. Pharmacy compounding of high-risk level products and patient safety;Mullarkey;Am J Health Syst Pharm,2009

4. It is time to review how unlicensed medicines are used;Sutherland;Eur J Clin Pharmacol,2015

5. European Parliament. Council of the European Union, Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, 2001.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Knowledge and Biocultural Heritage about Medicinal Plants in a European Transboundary Area (La Raya: Extremadura, Spain—Alentejo, Portugal): Transdisciplinary Research for Curriculum Design in Health Sciences;Heritage;2024-01-03

2. Extemporal production of medicines – advantages and prospects;Medical alphabet;2023-10-18

3. Compounding warning letters to 503A facilities between 2017 and 2021;Journal of the American Pharmacists Association;2023-09

4. Le temps est venu de mettre en œuvre un cadre de réglementation en matière de médicaments à usage pédiatrique au Canada;Canadian Medical Association Journal;2022-08-07

5. Time for a regulatory framework for pediatric medications in Canada;Canadian Medical Association Journal;2022-05-15